שווי כולל של החברה: TELA Bio, Inc. (TELA)

TELA Bio, Inc. (TELA) is a recognized innovator in tissue restoration that has earned physician trust through biocompatible implants that minimize postoperative risks. The asset's market dynamics show that the enterprise value is 69.53. The business relies on the supply of hybrid meshes to the hospital sector, covering the hernioplasty niche. A diversified network of external contractors ensures the company's stability, eliminating production disruptions during the manufacturing of matrices.

Enterprise Value (EV) represents the total buyout price of a business, combining market capitalization with net debt. By analyzing the enterprise value trend, an investor sees the actual costs of acquiring all company assets. This metric reflects the fundamental weight of the business, stripped of its financing structure. For TELA Bio, Inc. (TELA), this indicator is sensitive to operational risks and the cost of implementing regenerative technologies. Dependence on major contracts and expensive equipment directly impacts the final valuation.